$101.74
0.240.24%
At close: Dec 12, 4:00 PM EST
$101.50
-0.24-0.24%
Pre-Market: 8:30 AM EST
Comments
Loading...
Exact Sciences Stock Guidance | NASDAQ:EXAS | Benzinga
Exact Sciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/10/2025 | EXAS | Exact Sciences | FY | 2025 | — | — | — | $3.22B | $3.23B | $3.23B | Get Alert |
| 11/03/2025 | EXAS | Exact Sciences | FY | 2025 | — | — | — | $3.22B | $3.23B | $3.16B | Get Alert |
| 08/06/2025 | EXAS | Exact Sciences | FY | 2025 | — | — | — | $3.13B | $3.17B | $3.10B | Get Alert |
| 05/01/2025 | EXAS | Exact Sciences | FY | 2025 | — | — | — | $3.07B | $3.12B | $3.06B | Get Alert |
| 02/19/2025 | EXAS | Exact Sciences | FY | 2025 | — | — | — | $3.02B | $3.08B | $3.06B | Get Alert |
| 01/12/2025 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.76B | $2.76B | $2.74B | Get Alert |
| 01/12/2025 | EXAS | Exact Sciences | Q4 | 2024 | — | — | — | $713.00M | $713.00M | $694.76M | Get Alert |
| 11/05/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.73B | $2.75B | $2.83B | Get Alert |
| 07/31/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.81B | $2.85B | $2.83B | Get Alert |
| 06/03/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.81B | $2.85B | $2.83B | Get Alert |
| 06/03/2024 | EXAS | Exact Sciences | Q2 | 2024 | — | — | — | $677.00M | $697.00M | $690.49M | Get Alert |
| 05/08/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.81B | $2.85B | $2.83B | Get Alert |
| 02/21/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.81B | $2.85B | $2.83B | Get Alert |
| 01/07/2024 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.50B | $2.50B | $2.48B | Get Alert |
| 01/07/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.83B | $2.83B | $2.83B | Get Alert |
| 01/07/2024 | EXAS | Exact Sciences | Q4 | 2023 | — | — | — | $645.50M | $647.50M | $631.52M | Get Alert |
| 11/01/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.48B | $2.49B | $2.46B | Get Alert |
| 08/01/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.44B | $2.47B | $2.42B | Get Alert |
| 06/21/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.40B | $2.40B | $2.42B | Get Alert |
| 05/09/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.38B | $2.42B | $2.30B | Get Alert |
| 02/21/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.27B | $2.31B | $2.29B | Get Alert |
| 01/08/2023 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $2.08B | $2.08B | $2.03B | Get Alert |
| 01/08/2023 | EXAS | Exact Sciences | Q4 | 2022 | — | — | — | $550.70M | $552.70M | $506.48M | Get Alert |
| 11/03/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $2.02B | $2.04B | $2.01B | Get Alert |
| 08/02/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $1.98B | $2.02B | $2.02B | Get Alert |
| 04/26/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $1.99B | $2.03B | $2.01B | Get Alert |
| 02/22/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $1.98B | $2.03B | $1.99B | Get Alert |
| 01/09/2022 | EXAS | Exact Sciences | Q4 | 2021 | — | — | — | $472.00M | $475.00M | $440.30M | Get Alert |
| 01/09/2022 | EXAS | Exact Sciences | FY | 2021 | — | — | — | $1.76B | $1.77B | $1.73B | Get Alert |
FAQ
Q
What is the most recent guidance for Exact Sciences (EXAS)?
A
There have been no specific sales or earnings guidance reported for Exact Sciences in recent months.
Browse guidance and forecast on all stocks.
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved